HBK Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-80,574
Closed -$3.74M – 736
2019
Q1
$3.74M Buy
80,574
+19,735
+32% +$1,000K 0.04% 389
2018
Q4
$2.99M Buy
60,839
+3,586
+6% +$204K 0.03% 394
2018
Q3
$3.55M Buy
+57,253
New +$3.48M 0.03% 374
2018
Q2
– Sell
-4,950
Closed -$225K – 1059
2018
Q1
$225K Sell
4,950
-28,361
-85% -$1.22M ﹤0.01% 905
2017
Q4
$1.31M Sell
33,311
-23,827
-42% -$906K 0.01% 550
2017
Q3
$2.11M Buy
+57,138
New +$2.04M 0.01% 432
2016
Q1
– Sell
-19,609
Closed -$543K – 994
2015
Q4
$543K Buy
+19,609
New +$558K 0.01% 727
2015
Q1
– Sell
-7,919
Closed -$242K – 1038
2014
Q4
$242K Buy
+7,919
New +$247K ﹤0.01% 892

Other funds holding EHC

HBK Investments's EHC Position: Q2 2019 in Review

HBK Investments sold out of Encompass Health (EHC) in Q2 2019, closing a stake of 80,574 shares — an estimated $3.74M sold.

HBK Investments first reported a position in EHC in Q4 2014 and held it in 8 quarters. The position peaked at $3.74M in Q1 2019. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2019.

  • HBK Investments reported no remaining Encompass Health position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 80,574 Encompass Health shares in Q2 2019, an estimated $3.74M.
  • HBK Investments first reported a position in Encompass Health in Q4 2014 and held it in 8 quarters.
  • HBK Investments's Encompass Health position peaked at $3.74M in Q1 2019.
  • 395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.